ArticleJournal of hepatocellular carcinoma2022

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study.

Kongying Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.